by Kirsten Chalmers | Aug 17, 2022 | Health technology assessment, Healthcare, Market access, NICE
Designed to help healthcare stakeholders identify more urgent health needs, the concept of “unmet medical need” is being increasingly applied formally and informally to set priorities during the development, assessment, and reimbursement of new drugs and medical...
by Daniela Goncalves Bradley | May 25, 2022 | Clinical trial, Decision analytic, Evidence synthesis, Healthcare
Evidence synthesis aggregates all relevant information on a specific topic in order to draw well-informed, evidence-based decisions. It is an essential activity in recommending, providing and evaluating clinical care. If improperly done, however, evidence synthesis...
by Kristen Markus | Aug 13, 2021 | Evidence synthesis, Health outcomes, Healthcare, Market access
What is evidence synthesis? As the pharmaceutical market rapidly evolves to keep pace with patient needs and emerging research, healthcare decision makers must continuously re-evaluate the evidence base that informs their thinking. But how can they take into account...
